These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23280371)

  • 1. Pharmacokinetic considerations for targeted drug delivery.
    Yamashita F; Hashida M
    Adv Drug Deliv Rev; 2013 Jan; 65(1):139-47. PubMed ID: 23280371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular drug targeting, pharmacokinetics and bioavailability.
    Leucuta SE
    J Drug Target; 2014 Feb; 22(2):95-115. PubMed ID: 24188545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery systems: entering the mainstream.
    Allen TM; Cullis PR
    Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-based drug delivery.
    Pierigè F; Serafini S; Rossi L; Magnani M
    Adv Drug Deliv Rev; 2008 Jan; 60(2):286-95. PubMed ID: 17997501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution.
    Takakura Y; Hashida M
    Pharm Res; 1996 Jun; 13(6):820-31. PubMed ID: 8792417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
    Hunter AC; Elsom J; Wibroe PP; Moghimi SM
    Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of pharmacokinetic consideration for the development of drug delivery systems: A historical overview.
    Hashida M
    Adv Drug Deliv Rev; 2020; 157():71-82. PubMed ID: 32565225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Øie-Tozer model of drug distribution and its suitability for drugs with different pharmacokinetic behavior.
    Stepensky D
    Expert Opin Drug Metab Toxicol; 2011 Oct; 7(10):1233-43. PubMed ID: 21919805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of anticancer drugs.
    Zee-Cheng RK; Cheng CC
    Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seeing is believing--visualizing drug delivery in vitro and in vivo.
    Swartz H
    Adv Drug Deliv Rev; 2005 Jun; 57(8):1085-6. PubMed ID: 15935867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput in vitro drug release and pharmacokinetic simulation as a tool for drug delivery system development: application to intravitreal ocular administration.
    Sarkhel S; Ramsay E; Kontturi LS; Peltoniemi J; Urtti A
    Int J Pharm; 2014 Dec; 477(1-2):469-75. PubMed ID: 25445526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
    Souto EB; Müller RH
    Handb Exp Pharmacol; 2010; (197):115-41. PubMed ID: 20217528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comprehensive Insight Towards Pharmaceutical Aspects of Graphene Nanosheets.
    Emadi F; Emadi A; Gholami A
    Curr Pharm Biotechnol; 2020; 21(11):1016-1027. PubMed ID: 32188383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential properties of drug-targeting delivery systems.
    Petrak K
    Drug Discov Today; 2005 Dec; 10(23-24):1667-73. PubMed ID: 16376827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of gene drug delivery systems based on pharmacokinetic studies.
    Takakura Y; Nishikawa M; Yamashita F; Hashida M
    Eur J Pharm Sci; 2001 Apr; 13(1):71-6. PubMed ID: 11292570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
    Sudhakar Y; Kuotsu K; Bandyopadhyay AK
    J Control Release; 2006 Aug; 114(1):15-40. PubMed ID: 16828915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of glycosylated carriers for drug delivery.
    Jain K; Kesharwani P; Gupta U; Jain NK
    Biomaterials; 2012 Jun; 33(16):4166-86. PubMed ID: 22398205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomic considerations in drug delivery.
    Attar M; Lee VH
    Pharmacogenomics; 2003 Jul; 4(4):443-61. PubMed ID: 12831323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.